Navigation Links
Vanda Pharmaceuticals Announces Commencement of Clinical Study of Long-Acting Injectable Formulation of Fanapt®
Date:4/11/2011

cialize Vanda's products under its license and sublicense agreements and other factors that are described in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of Vanda's annual report on Form 10-K for the fiscal year ended December 31, 2010, which is on file with the SEC and available on the SEC's website at http://www.sec.gov/.  In addition to the risks described above and in Vanda's annual report on Form 10-K, other unknown or unpredictable factors also could affect Vanda's results. There can be no assurance that the actual results or developments anticipated by Vanda will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, Vanda. Therefore, no assurance can be given that the outcomes stated in such forward-looking statements and estimates will be achieved.

All written and verbal forward-looking statements attributable to Vanda or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements contained or referred to herein. Vanda cautions investors not to rely too heavily on the forward-looking statements Vanda makes or that are made on its behalf. The information in this release is provided only as of the date of this release, and Vanda undertakes no obligation, and specifically declines any obligation, to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

Media/Investor Inquiries
Cristina Murphy
Cristina.murphy@vandapharma.com
240-599-4500


'/>"/>
SOURCE Vanda Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Vanda Pharmaceuticals to Evaluate Tasimelteon in Major Depression
2. Vanda Pharmaceuticals Receives Orphan Drug Designation in Europe for tasimelteon
3. Vanda Pharmaceuticals Files Shelf Registration Statement
4. Vanda Pharmaceuticals Appoints Chief Financial Officer
5. Vanda Pharmaceuticals Reports Third Quarter 2010 Results
6. Vanda Pharmaceuticals to Announce Third Quarter 2010 Financial Results on November 3, 2010
7. Vanda Pharmaceuticals Initiates Phase III Clinical Study Aimed at Resetting the Body Clock
8. Vanda Pharmaceuticals Adds Former U.S. Surgeon General, Steven Galson, to its Board of Directors
9. Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders
10. Vanda Pharmaceuticals Announces U.S. Patent Allowance for a Long-Acting Injectable Formulation of Fanapt(TM) (iloperidone) in the U.S.
11. Vanda Pharmaceuticals Announces Expiration of Hart-Scott -Rodino Waiting Period for Exclusive License of Fanapt(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)...  Reportlinker.com announces that a new market research report ... and Taiwanese Markets for Minimally Invasive Spinal Devices ... The market for MIS spinal devices in the ... at a fast pace, albeit at different rates in ... China , where MIS spinal fusion ...
(Date:9/2/2014)... , Sept. 2, 2014 The Pharmaceutical Care ... benefit managers (PBMs), today filed a lawsuit in ... new Iowa law that restricts ... for the state,s employers and consumers.  ... by severely restricting the use of Maximum Allowable Cost ...
(Date:9/2/2014)... 2, 2014  XBiotech announced today interim results ... in the US for its anti-cancer agent Xilonix™. ... therapy, is being evaluated in advanced colorectal cancer ... The primary endpoint of the study is overall ... a control population provided only palliative therapy for ...
Breaking Medicine Technology:Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 2Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 3Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 4Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 5Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 6Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 7Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 8Chinese and Taiwanese Markets for Minimally Invasive Spinal Devices 9Lawsuit Challenges Iowa Health Mandate that Forces Employers to Pay More for Prescription Drugs 2XBiotech Halts Study, Reports Positive Phase III Results with Antibody Therapy for Cancer 2
... , , , , , , MUMBAI, India, Dec. ... IN, NSE: SUNPHARMA, BSE: 524715) today announced that Glass, Lewis ... that shareholders of Taro Pharmaceutical Industries Ltd. (Pink Sheets: TAROF) ... of directors, including all of its nominees for election or ...
... , SUNNYVALE, Calif., Dec. 22 Arrayit Corporation (OTC Bulletin ... announced that the Company has made a technological breakthrough in ... microarrays, which are tiny glass substrates that contain rows and ... diagnostics. The advance allows highly precise printing of as many ...
Cached Medicine Technology:Glass Lewis Advises Taro Shareholders to Hold Taro's Board Accountable for Its Failures 2Glass Lewis Advises Taro Shareholders to Hold Taro's Board Accountable for Its Failures 3Glass Lewis Advises Taro Shareholders to Hold Taro's Board Accountable for Its Failures 4Arrayit Corporation Announces Manufacturing Breakthrough 2Arrayit Corporation Announces Manufacturing Breakthrough 3
(Date:9/2/2014)... (PRWEB) September 03, 2014 Autumn ... Top10BestSEOHosting.com wants to celebrate the new season with ... of research and announced that Hostgator ( http://secure.hostgator.com/~affiliat/cgi-bin/affiliates/clickthru.cgi?id=seohosts ... hosting suppliers of 2014. , Since 2002 ... hosting provider, and the company’s reputation for reliability ...
(Date:9/2/2014)... pot might be risky business for women, according ... study is the first to demonstrate sex differences ... , Psychology professor Rebecca Craft showed that, thanks ... least 30 percent more sensitive than males to ... in cannabis. Females also develop tolerance to THC ...
(Date:9/2/2014)... Angeles, CA (PRWEB) September 03, 2014 ... health enthusiasts, bodybuilders, and athletes obtain the latest ... its launch. The site, which focuses mainly on ... dedicated to helping individuals increase their workout capacity ... an article available on Top Creatine Monohydrate, Muscle ...
(Date:9/2/2014)... September 02, 2014 Becker's Healthcare ... Officer and Chief Information Officer Strategy Roundtables on ... , Becker's Hospital Review Chief Executive Officer and ... and health system Chief Executive Officers, Chief Financial ... health system executives through high-quality continuing education, ...
(Date:9/2/2014)... Recently, BambooIndustry.com, an excellent company in the bamboo industry, ... bamboo floors to celebrate the coming of autumn. ... the frequent callers, BambooIndustry.com launched a promotion for its ... woven floors, BambooIndustry.com provides many kinds of wonderful items ... woven floors, click lock floors, wide plank floors and ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com Celebrates The Coming Of Autumn And Release Reseller Hosting Suppliers Of 2014 2Health News:Estrogen increases cannabis sensitivity 2Health News:Estrogen increases cannabis sensitivity 3Health News:Creatine Monohydrate Reviews Site TopCreatineMonohydrate.com Announces its Launch 2Health News:Becker's Healthcare Announces Hospital CEO and CIO Strategy Roundtables 2Health News:Becker's Healthcare Announces Hospital CEO and CIO Strategy Roundtables 3Health News:Becker's Healthcare Announces Hospital CEO and CIO Strategy Roundtables 4Health News:Cheap Strand Woven Bamboo Floors For Autumn On Sale At BambooIndustry.com 2
... Inc. (Nasdaq: MEDQ ), the largest Medical Transcription ... the positive resolution of several material legal matters , ... Investigation , , As ... documents from the United States Department of Justice ("DOJ") on ...
... College of Surgeons (ACS) today recognized the Institute of Medicine ... was released on December 2, 2008, by the IOM Committee ... to Improve Patient Safety. , ... conclusion that further reductions in the mandated 80-hour work week ...
... YORK, Dec. 3, 2008 Forest Laboratories, Inc. (NYSE: ... of an unsolicited mini-tender offer by TRC Capital Corporation (TRC) ... has received a copy of the tender offer to purchase ... stock, which represents less than 1 per cent of its ...
... MAP,Pharmaceuticals, Inc. (Nasdaq: MAPP ) today announced ... "Adapting Specialty Pharma Strategy,To Market Conditions" at the 2008 ... at 10:00 am (ET) in New York City. , ... of the panel discussion will be available on the ...
... outperform animal and human derived serum in CHO cell culture. ... ... Cellastim has proven to be a robust replacement for serum derived ... and productivity of CHO cell lines across a variety of chemically ...
... N.J., Dec. 3 As previously announced, HLTH Corporation (Nasdaq: ... (Nasdaq: WBMD ), will be holding their Annual Meetings ... 10, 2008. , , ... the Internet. To listen to the audio webcast of the meetings, ...
Cached Medicine News:Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 2Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 3Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 4Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 5Health News:MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits 6Health News:American College of Surgeons Comments on Institute of Medicine Report on Resident Duty Hours 2Health News:Forest Laboratories Responds To Unsolicited Mini-Tender Offer 2Health News:Forest Laboratories Responds To Unsolicited Mini-Tender Offer 3Health News:InVitria's Cellastim Delivers Superior Results in CHO Cell Culture 2Health News:HLTH Corporation and WebMD to Webcast Annual Meetings of Stockholders 2
...
... The mecA ASR contains primers and a FAM-labeled ... bp region of the mecA gene. In addition, ... and DNA for an internal control sequence. This ... and Texas Red reporter dyes such as the ...
... features the ability to use a separate, ... a pre-loaded nitinol filter with a dual-ended ... fully rapid exchange system, the SpideRX Device ... applications:, Carotid Indication - ,The SpideRX Embolic ...
Pefakit PiCT DxS Diluent for Determination of Total Heparin...
Medicine Products: